Lumonus, a healthcare technology company transforming cancer care with its AI-powered platform, announced a multi-year agreement with Smarter Radiation Oncology® (SRO), a company incubated by Northwell Health. Together, the organizations will advance the delivery of high-quality, standardized radiation therapy by combining Lumonus AI with SRO's evidence-based treatment protocols.

Lumonus' AI Physician platform simplifies oncology workflows by automating administrative tasks such as clinical preparation and documentation. By embedding SRO directives into the platform, clinicians will be able to access validated, real-world prescribing standards directly at the point of care. This integration supports faster, safer, and more consistent treatment decisions for patients.

"Smarter Radiation Oncology reflects years of work to improve quality and consistency in radiation therapy across our network," said Louis Potters, MD, Chair of Radiation Medicine at Northwell Health. "Through this licensing agreement with Lumonus, we can now make these standards available more broadly to the global oncology community."

Keith Hansen, CEO of Lumonus, added: "Working with SRO allows us to incorporate their proven directives into the Lumonus AI Physician platform, giving cancer centers access to evidence-based prescribing standards. Together, we are helping physicians deliver safer, more efficient care while keeping pace with the latest clinical evidence."